Literature DB >> 22697074

Toll-like receptor kinetics in septic shock patients: a preliminary study.

O Piazza1, G Pulcrano, P L Fiori, R Tufano, M Lonardo, F Rossano, M R Catania.   

Abstract

The aim of this study is to evaluate some inflammatory parameter changes in septic shock patients and their possible correlation with clinical outcome, in particular when continuous veno-venous hemofiltration (CVVH) treatment is required. Considering the objective difficulty in enrolling this kind of patient, a preliminary study was initiated on seventeen septic shock patients admitted to a medical and surgical ICU. The mRNA expression of Toll-like receptor (TLR)-1, TLR-2, TLR-4, TLR-5, TLR-9, TNFα, IL-8 and IL-1β was assessed, the plasmatic concentrations of IL-18, IL-2, IL-10 and TNFα were measured on the day of sepsis diagnosis and after 72 h. In those patients who developed acute renal failure unresponsive to medical treatment and who underwent CVVH treatment the same parameters were measured every 24 h during CVVH and after completion of the treatment. On sepsis diagnosis, gene expression of TLRs was up-regulated compared to the housekeeping gene in all the patients. After 72 h, in 35% of the patients a down-regulation of these genes was found compared to day 1, but it was not associated with a reduction of cytokine serum levels or improved clinical signs, better outcome or reduced mortality. After high volume hemofiltration treatment, cytokine serum levels and TLR expression were not significantly modified. In conclusion, considering the not numerous number of cases, from our preliminary study, we cannot certainly correlate TLR over-expression in septic shock patients with severity or outcome scores.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22697074     DOI: 10.1177/039463201202500212

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  6 in total

1.  Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients.

Authors:  Jon D Simmons; Mark N Gillespie
Journal:  Coron Artery Dis       Date:  2015-06       Impact factor: 1.439

2.  Toll-like receptor 2 in serum: a potential diagnostic marker of prosthetic joint infection?

Authors:  Emanuela Galliera; Lorenzo Drago; Christian Vassena; Carlo Romanò; Monica Gioia Marazzi; Lucia Salcito; Massimiliano M Corsi Romanelli
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

3.  The Relationship Between Sepsis-induced Immunosuppression and Serum Toll-like Receptor 9 Level.

Authors:  Nazan Atalan; Leyla Acar; Nihan Yapici; Turkan Kudsioglu; Arzu Ergen; Seda Gulec Yilmaz; Turgay Isbir
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

4.  Minimally invasive Swine experimental model for the in vivo study of liver metabolism of drugs.

Authors:  O Piazza; R Romano; G Scarpati; C Esposito; E Cavaglià; M Corona
Journal:  Transl Med UniSa       Date:  2012-10-11

5.  Dopamine Use in Intensive Care: Are We Ready to Turn it Down?

Authors:  Geremia Zito Marinosci; Edoardo De Robertis; Giuseppe De Benedictis; Ornella Piazza
Journal:  Transl Med UniSa       Date:  2012-10-11

6.  Management of sepsis in asplenic patients.

Authors:  Piazza Ornella
Journal:  Transl Med UniSa       Date:  2013-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.